Continuous and reversible transformation of the polymorphs of an MGAT2 inhibitor (S-309309) from the anhydrate to the hydrate in response to relative humidity

Hiroshi Ueda,Katsuji Sugita,Tetsuya Miyano

DOI: https://doi.org/10.26434/chemrxiv-2024-m9qp7

2024-06-20

Abstract:Quality control is a strict requirement of pharmaceutical manufacture. The stability of a drug can be enhanced by crystallization owing to the relatively low energy of a crystal lattice. Herein, we investigated the hydrate and anhydrate polymorphs of a monoacylglycerol acyltransferase 2 inhibitor (S-309309) to elucidate their relationship with each other. Polymorphic screening by solvent evaporation and slurry conversion revealed two polymorphs: Form I (the hydrate) and Form II (the solvate). Form II transformed to Form I during thermogravimetry–differential thermal analysis. X-ray powder diffraction demonstrated that Form I transformed to the anhydrate via an intermediate state when heated. These crystal forms were confirmed under controlled humidity conditions; the presence of the anhydrate, the intermediate hydrate, or the hydrate depended on the relative humidity at 25°C. The stoichiometry of S-309309 to water in the hydrate form was 4:1. The hydrate and anhydrate had similar crystal structures. The water of hydration in the intermediate hydrate was 0.1–0.15 mol according to the dynamic vapor sorption profile. We discovered a mechanism of reversible crystal transformation between the anhydrate and pseudo-polymorphs of the hydrate at ambient humidity. We conclude that S-309309 should be treated carefully because the experimental conditions affect its crystal form.

Chemistry

What problem does this paper attempt to address?

This paper mainly discusses the continuous and reversible conversion phenomenon between two polymorphs of the drug MGAT2 inhibitor (S-309309) - hydrate (Form I) and anhydrous (Form II), which is related to relative humidity. The researchers discovered these two polymorphs through solvent evaporation and suspension conversion methods, and studied their physicochemical properties and transformation mechanisms through techniques such as thermogravimetric analysis-differential scanning calorimetry (TG-DTA) and X-ray powder diffraction (XRD).

Under different humidity conditions, Form I can be converted into intermediate states and anhydrous states with different amounts of water molecules. During the heating process, Form I is converted into anhydrous form, while anhydrous form can be transformed into an intermediate hydrated state and further transformed into Form I when humidity increases. The proportion of water molecules in Form I was determined through dynamic vapor sorption (DVS) experiments, and it was found that this transformation process is reversible.

The paper also discusses the importance of polymorphs in drug manufacturing, as different polymorphs may affect the stability and pharmacological activity of drugs. For S-309309, the influence of experimental conditions on crystal form suggests the need for careful handling to ensure control of its crystal form.

In conclusion, this study reveals the polymorphic transformation mechanism of the MGAT2 inhibitor S-309309, which is of great significance for drug development and quality control, especially in considering drug stability, solubility, and characterization of new polymorphs.